Novo Nordisk A/S
Insulin derivatives and the medical uses hereof

Last updated:

Abstract:

The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes. More specifically the invention relates to novel acylated derivatives of human insulin analogues. The invention also provides pharmaceutical compositions comprising such insulin derivatives, and relates to the use of such derivatives for the treatment or prevention of medical conditions relating to diabetes.

Status:
Grant
Type:

Utility

Filling date:

24 Aug 2016

Issue date:

7 Jun 2022